<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01115140</url>
  </required_header>
  <id_info>
    <org_study_id>01/2010</org_study_id>
    <nct_id>NCT01115140</nct_id>
  </id_info>
  <brief_title>Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women</brief_title>
  <official_title>Effect of Metformin With or Without Folate Addiction on Uterine Blood Flow and Trophoblastic Invasion in Pregnant Patients With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Magna Graecia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Magna Graecia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A more recent prospective nonrandomized placebo-controlled double-blind clinical study
      demonstrated that metformin exerts a slight but significant deleterious effect on serum
      homocysteine (Hcy) levels in patients with PCOS, and supplementation with folate is useful to
      increase the beneficial effect of metformin on the vascular endothelium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PCOS (cases) and non-PCOS (controls) pregnant women were enrolled. Cases will be randomized
      in four treatment groups: metformin plus placebo (group A1), metformin plus folic acid (group
      A2), placebo plus folic acid (group A3), placebo alone (group A4). Controls will not received
      any treatment (group B). Clinical and biochemical assessment (including serum markers of
      implantation), Doppler velocimetry of the uterine arteries, and trophoblastic invasion at
      histological and immunohistochemical evaluation.

      Changes in clinical and biochemical data under treatment, pattern of Doppler velocimetry at
      the uterine arteries, and trophoblastic invasion were evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trophoblastic invasion.</measure>
    <time_frame>two weeks</time_frame>
    <description>Istologic evaluation of trophoblastic ivasion,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Doppler velocimetry measurements of the uterine artery.</measure>
    <time_frame>two weeks</time_frame>
    <description>Ultrasonographyc assessment of Doppler velocimetry measurements of the uterine artery.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Pregnancy</condition>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Group A1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>metformin plus placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group A2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>metformin plus folic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group A3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>placebo plus folic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group A4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo cp, 2 cps daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>observation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metformin plus placebo</intervention_name>
    <description>metformin 850 mg cp, 2 cps daily</description>
    <arm_group_label>Group A1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin plus folic acid</intervention_name>
    <description>metformin 850 mg cp, 2 cps daily plus folic acid 0.4 mg daily</description>
    <arm_group_label>Group A2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo plus folic acid</intervention_name>
    <description>Placebo 1 cp daily plus folic acid 0.4 mg daily</description>
    <arm_group_label>Group A3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo alone</intervention_name>
    <description>placebo cp, 2 cps daily</description>
    <arm_group_label>Group A4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnancy

          -  PCOS

        Exclusion Criteria:

          -  Risk factors for pregnancy complications

          -  Severe obesity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fulvio Zullo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefano Palomba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>&quot;Pugliese&quot; Hospital</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2010</study_first_submitted>
  <study_first_submitted_qc>May 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2010</study_first_posted>
  <last_update_submitted>May 23, 2011</last_update_submitted>
  <last_update_submitted_qc>May 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 24, 2011</last_update_posted>
  <responsible_party>
    <name_title>Department of Obstetrics and Gynecology</name_title>
    <organization>University Magna Graecia</organization>
  </responsible_party>
  <keyword>Folate</keyword>
  <keyword>Metformin</keyword>
  <keyword>PCOS</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Trophoblastic invasion</keyword>
  <keyword>Uterine artery velocimetry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

